The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with an estimated prevalence of about 1/3000, independent of ethnicity, race, or gender. Attention Deficit Hyperactivity like Disorder (ADHD)-like characteristics are often reported in patients with NF1. We hypothesised tha...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lion-François, Laurence, Gueyffier, François, Mercier, Catherine, Gérard, Daniel, Herbillon, Vania, Kemlin, Isabelle, Rodriguez, Diana, Ginhoux, Tiphanie, Peyric, Emeline, Coutinho, Virginie, Bréant, Valentine, des Portes, Vincent, Pinson, Stéphane, Combemale, Patrick, Kassaï, Behrouz
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4172829/
https://ncbi.nlm.nih.gov/pubmed/25205361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-014-0142-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia